Related Experiment Video
Updated: Jul 31, 2026
07:15
Invasion of Human Cells by a Bacterial Pathogen
Published on: March 21, 2011
Hemagglutination inhibition assay for gentamicin
Antimicrobial Agents and Chemotherapy
|February 1, 1977
Summary
A new hemagglutination inhibition test offers a fast and reliable method for measuring gentamicin levels in serum. This simple assay shows strong correlation with existing methods, making it valuable for laboratory use.
Area of Science:
- Clinical Chemistry
- Immunology
- Pharmacology
Background:
- Accurate measurement of gentamicin serum concentrations is crucial for therapeutic drug monitoring.
- Existing methods like radioimmunoassay and microbiological assay can be time-consuming or complex.
Purpose of the Study:
- To develop and validate a rapid, simple, and cost-effective hemagglutination inhibition (HI) assay for quantifying gentamicin in human serum.
Main Methods:
- Development of a hemagglutination inhibition test.
- Comparison of gentamicin serum concentrations measured by HI assay against radioimmunoassay (RIA) and microbiological assay (MBA).
- Statistical analysis of correlation coefficients and significance of differences between methods.
Main Results:
- The developed hemagglutination inhibition assay demonstrated high correlation coefficients with both radioimmunoassay (r = 0.710) and microbiological assay (r = 0.864).
- No statistically significant differences were observed in gentamicin measurements between the HI assay and the established methods.
- The HI assay is characterized by its speed, reliability, and cost-effectiveness.
Conclusions:
- The hemagglutination inhibition assay is a valid and reliable method for determining gentamicin concentrations in serum.
- This assay presents a valuable alternative for routine laboratory use due to its simplicity and efficiency.
- The findings support the utility of the HI assay in clinical settings for therapeutic drug monitoring of gentamicin.
